Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanoma 2.0. Skin cancer as a paradigm for emerging diagnostic technologies, computational modelling and artificial intelligence.
Vera J, Lai X, Baur A, Erdmann M, Gupta S, Guttà C, Heinzerling L, Heppt MV, Kazmierczak PM, Kunz M, Lischer C, Pützer BM, Rehm M, Ostalecki C, Retzlaff J, Witt S, Wolkenhauer O, Berking C. Vera J, et al. Among authors: heinzerling l. Brief Bioinform. 2022 Nov 19;23(6):bbac433. doi: 10.1093/bib/bbac433. Brief Bioinform. 2022. PMID: 36252807 Review.
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.
Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kähler KC, Gesierich A, Meissner M, von Bubnoff D, Göppner D, Schlaak M, Pföhler C, Utikal J, Heinzerling L, Cosgarea I, Engel J, Eckel R, Martens A, Mirlach L, Satzger I, Schubert-Fritschle G, Tietze JK, Berking C. Heppt MV, et al. Among authors: heinzerling l. Eur J Cancer. 2017 Aug;81:36-44. doi: 10.1016/j.ejca.2017.05.014. Epub 2017 Jun 7. Eur J Cancer. 2017. PMID: 28600969
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C. Heppt MV, et al. Among authors: heinzerling l. Eur J Cancer. 2017 Sep;82:56-65. doi: 10.1016/j.ejca.2017.05.038. Epub 2017 Jun 22. Eur J Cancer. 2017. PMID: 28648699
Interest in tanning beds and sunscreen in German-speaking countries.
Kirchberger MC, Kirchberger LF, Eigentler TK, Reinhard R, Berking C, Schuler G, Heinzerling L, Heppt MV. Kirchberger MC, et al. Among authors: heinzerling l. J Dtsch Dermatol Ges. 2017 Dec;15(12):1192-1198. doi: 10.1111/ddg.13380. Epub 2017 Nov 17. J Dtsch Dermatol Ges. 2017. PMID: 29148618
Das Interesse an Solarien und Sonnenschutz im deutschsprachigen Raum.
Kirchberger MC, Kirchberger LF, Eigentler TK, Reinhard R, Berking C, Schuler G, Heinzerling L, Heppt MV. Kirchberger MC, et al. Among authors: heinzerling l. J Dtsch Dermatol Ges. 2017 Dec;15(12):1192-1198. doi: 10.1111/ddg.13380_g. J Dtsch Dermatol Ges. 2017. PMID: 29228492 No abstract available.
A web platform for the network analysis of high-throughput data in melanoma and its use to investigate mechanisms of resistance to anti-PD1 immunotherapy.
Dreyer FS, Cantone M, Eberhardt M, Jaitly T, Walter L, Wittmann J, Gupta SK, Khan FM, Wolkenhauer O, Pützer BM, Jäck HM, Heinzerling L, Vera J. Dreyer FS, et al. Among authors: heinzerling l. Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt B):2315-2328. doi: 10.1016/j.bbadis.2018.01.020. Epub 2018 Feb 23. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29410200 Free article.
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients.
Kirchberger MC, Ugurel S, Mangana J, Heppt MV, Eigentler TK, Berking C, Schadendorf D, Schuler G, Dummer R, Heinzerling L. Kirchberger MC, et al. Among authors: heinzerling l. Eur J Cancer. 2018 Jul;98:10-16. doi: 10.1016/j.ejca.2018.04.010. Epub 2018 May 26. Eur J Cancer. 2018. PMID: 29843107
Senescence markers: Predictive for response to checkpoint inhibitors.
Moreira A, Gross S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L. Moreira A, et al. Among authors: heinzerling l. Int J Cancer. 2019 Mar 1;144(5):1147-1150. doi: 10.1002/ijc.31763. Epub 2018 Dec 4. Int J Cancer. 2019. PMID: 30151962 Free article.
226 results